Inhibition of IDO activity by NLG919 reverses the immunosuppressive tumor microenvironment, chemotherapy drugs are precisely activated in the presence of near‐infrared light, triggering immunogenic cell death (ICD). This evidence concerns the gene IDO1 and neoplasm.